Biontech and instadeep developed and successfully tested early warning system to detect potential high-risk sars-cov-2 variants

Mainz, germany and london, united kingdom, january 11, 2022 — biontech se (nasdaq: bntx, “biontech”) and instadeep ltd (“instadeep”) today announced the development of a new computational method that analyses worldwide available sequencing data and predicts high-risk variants of sars-cov-2. the early warning system (ews) developed in collaboration by biontech and instadeep is based on artificial intelligence (ai) calculated immune escape and fitness metrics.
BNTX Ratings Summary
BNTX Quant Ranking